(Q34195066)

English

Impact of antiretroviral therapy interruption on plasma biomarkers of cardiovascular risk and lipids: 144-week final data from the STOPAR study.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Impact of antiretroviral therapy interruption on plasma biomarkers of cardiovascular risk and lipids: 144-week final data from the STOPAR study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

0 references

Carlos Alonso Villaverde

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

M Olmo

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

M Saumoy

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

M Peñaranda

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

F Gutiérrez

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

J Romeu

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

M Larrousse

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

J Curto

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

P Domingo

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

J A Oteo

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

A Vila

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

D Podzamczer

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

publication date

14 March 2012

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

13

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

488-498

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

CD4+ count-guided interruption of antiretroviral treatment

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAART.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Metabolic and immune activation effects of treatment interruption in chronic HIV-1 infection: implications for cardiovascular risk

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Changes in lipids and lipoprotein particle concentrations after interruption of antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Lipid and apoprotein profile in HIV-1-infected patients after CD4-guided treatment interruption

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Increased soluble vascular cell adhesion molecule-1 plasma levels and soluble intercellular adhesion molecule-1 during antiretroviral therapy interruption and retention of elevated soluble vascular cellular adhesion molecule-1 levels following resum

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

HIV increases markers of cardiovascular risk: results from a randomized, treatment interruption trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Cardiovascular disease in HIV-positive patients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Endothelial function in human immunodeficiency virus-infected antiretroviral-naive subjects before and after starting potent antiretroviral therapy: The ACTG (AIDS Clinical Trials Group) Study 5152s.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Tissue plasminogen activator antigen and coronary heart disease. Prospective study and meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

The adhesion molecule P-selectin and cardiovascular disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Antiretroviral therapy reduces markers of endothelial and coagulation activation in patients infected with human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunction

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Effect of highly active antiretroviral therapy on biomarkers of B-lymphocyte activation and inflammation

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Human immunodeficiency virus-infection induces major changes in high-density lipoprotein particle size distribution and composition: the effect of antiretroviral treatment and disease severity.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Apolipoprotein A-I inhibits chemotaxis, adhesion, activation of THP-1 cells and improves the plasma HDL inflammatory index

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Paraoxonase-1 inhibits oxidised LDL-induced MCP-1 production by endothelial cells

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Soluble CD40 Ligand in Acute Coronary Syndromes

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2012.01000.X

21 January 2018

Identifiers

10.1111/J.1468-1293.2012.01000.X

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22416676%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34195066&oldid=1104306528"